Related Experiment Video
Updated: Jul 4, 2025

09:45
Author Spotlight: Detecting Low-Abundant Host Cell Proteins in Drug Products Using Enrichment Beads and Limited Digestion
Published on: January 19, 2024
2.2K
Host Cell Protein Analysis using Enrichment Beads Coupled with Limited Digestion
Sisi Zhang1, Hui Xiao2, Ning Li1
1Analytical Chemistry, Regeneron Pharmaceuticals Inc.
Journal of Visualized Experiments : Jove
|February 5, 2024
Summary
This study presents a user-friendly protocol for enriching host cell proteins (HCPs) and removing monoclonal antibodies (mAbs) using proteome enrichment beads. The method achieves over 7000-fold HCP enrichment, enabling sensitive detection for drug product safety.
Area of Science:
- Biotechnology
- Analytical Chemistry
- Proteomics
Background:
- Host cell proteins (HCPs) are critical impurities in therapeutic protein products, posing potential risks even at low concentrations.
- Accurate identification and quantification of HCPs are essential for drug safety and regulatory compliance.
- Existing methods for HCP detection often require sensitive enrichment strategies to overcome low abundance challenges.
Purpose of the Study:
- To develop and validate a user-friendly protocol for the enrichment of low-abundance host cell proteins (HCPs) from therapeutic protein samples.
- To simultaneously remove monoclonal antibodies (mAbs) to improve HCP detection sensitivity.
- To establish a highly sensitive method for HCP detection using liquid chromatography-mass spectrometry (LC-MS).
Main Methods:
- Utilized commercially available proteome enrichment beads with a diverse library of hexapeptide ligands for HCP enrichment.
- Implemented a limited digestion protocol followed by peptide detection using nano liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS).
- Developed a protocol integrating HCP enrichment and mAb removal prior to LC-MS analysis.
Main Results:
- Achieved over 7000-fold enrichment of host cell proteins (HCPs).
- Established a detection limit as low as 0.002 ppm for HCPs.
- Successfully detected 850 HCPs with high confidence in a NIST mAb reference standard.
- Demonstrated a user-friendly protocol with a video demonstration for implementation.
Conclusions:
- The developed protocol offers a highly sensitive and effective method for enriching and detecting low-abundance HCPs.
- This approach significantly enhances the accuracy of risk assessment for therapeutic protein drug products.
- The user-friendly nature and high sensitivity of the protocol facilitate its adoption in biopharmaceutical quality control.

